Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Buy
65
ALGS Quote, Financials, Valuation and Earnings
Last price:
$41.28
Seasonality move
:
-16.03%
Day range:
$38.13 - $43.94
52-week range:
$6.76 - $43.94
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
39.39x
P/B ratio:
3.11x
Volume:
784.9K
Avg. volume:
514.3K
1-year change:
135.07%
Market cap:
$155.6M
Revenue:
$15.5M
EPS (TTM):
-$17.11
Earnings Data
Next earnings date for ALGS
Mar 12
2025
Most recent earnings per share
-$3.07
Missed by $1.75
(Nov 6/2024)
Consensus Estimate
-$1.33
(Nov 6/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ALGS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/12/2025 | Q4 | $433.3K | -- | -- | -$3.67 | -- |
| 11/06/2024 | Q3 | $333.3K | $1.3M | -$3.07 | -$1.33 | -$1.75 |
| 08/06/2024 | Q2 | -- | $1.1M | $0.75 | -$4.00 | $4.75 |
| 05/07/2024 | Q1 | -- | $986K | -$5.50 | -$4.75 | -$0.75 |
| 03/12/2024 | Q4 | $1.6M | $2.7M | -$9.29 | -$6.75 | -$2.54 |
| 11/02/2023 | Q3 | -- | -- | -$10.37 | -$11.88 | $1.51 |
| 08/03/2023 | Q2 | -- | -- | -$10.75 | -$12.38 | $1.63 |
| 05/04/2023 | Q1 | -- | -- | -$13.25 | -$12.13 | -$1.13 |
| 03/09/2023 | Q4 | -- | -- | -$12.75 | -$12.67 | -$0.08 |
| 11/02/2022 | Q3 | -- | -- | -$11.00 | -$14.52 | $3.52 |
| 08/04/2022 | Q2 | -- | -- | -$11.75 | -- | -- |
| 05/04/2022 | Q1 | -- | -- | -$21.00 | -- | -- |
| 03/10/2022 | Q4 | -- | -- | -$22.25 | -- | -- |
| 11/04/2021 | Q3 | -- | -- | -$19.50 | -- | -- |
| 08/05/2021 | Q2 | -- | -- | -$19.75 | -- | -- |
| 05/10/2021 | Q1 | -- | -- | -$18.50 | -- | -- |
| 03/23/2021 | Q4 | -- | -- | -$27.25 | -- | -- |
| 11/25/2020 | Q3 | -- | -- | -$22.56 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$23.71 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$22.83 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$20.73 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$16.02 | -- | -- |
Aligos Therapeutics Earnings Questions
-
How Much did Aligos Therapeutics Generate in Revenue Last Quarter?
Aligos Therapeutics reported $1.3M worth of top line sales in its most recent quarter.
-
Did Aligos Therapeutics Beat Earnings Last Quarter?
Aligos Therapeutics announced earnings per share of -$3.07 which represents a miss of analyst forecast a -$1.33 per share.
-
Is Aligos Therapeutics Profitable?
Aligos Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Aligos Therapeutics EPS Next Year?
Aligos Therapeutics's earnings are forecast to decrease from -$34.00 per share to -$41.25 per share next year representing a decrease of -69.53%.
-
When is Aligos Therapeutics's Earnings Date?
Aligos Therapeutics's next earnings date is March 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
